Shares of Canadian pot company Cronos slide after revenue disappoints

Shares of Canadian pot company Cronos slid by more than 5 percent Tuesday after the company reported disappointing fourth-quarter revenue.

Source link

Leave a Comment

Fresenius Medical Care to pay $231 million to resolve criminal, civil foreign bribery chargesPregabalin/Lyrica reclassified to a class C drug